Lee Ann
Lee Ann Paynter is an artist, an activist and an educator. She received her MFA in Photography and Media from California Institute of the Arts in 2011, and is a Lecturer in the School of Art and Visual Studies. Her oeuvre consists of traditional methods of photography, digital media, video installation, social engagement and interventions.
lee ann
Each quarter Lee Ann will share a series of videos directed to buyers and sellers with advice from anything to staging your home, the state of the current local market to news announcements from the Lee Ann Wilkinson Group!
The beach towns of coastal Delaware each have their own style and allure, and each with their own reason to become your favorite. Whether it's the hometown charm of Lewes, the nightlife of Rehoboth Beach or the highly rated restaurants of Bethany Beach, you can find something for everyone in each of our small towns that has people not only coming back every summer but staying permanently! Discover one of these featured neighborhoods to call home. Live Your Beach Life.
The data relating to real estate for sale on this website appears in part through the BRIGHT Internet Data Exchange program, a voluntary cooperative exchange of property listing data between licensed real estate brokerage firms in which Berkshire Hathaway HomeServices Gallo Realty participates, and is provided by BRIGHT through a licensing agreement. The information provided by this website is for the personal, non-commercial use of consumers and may not be used for any purpose other than to identify prospective properties consumers may be interested in purchasing. Some properties which appear for sale on this website may no longer be available because they are under contract, have Closed or are no longer being offered for sale. Some real estate firms do not participate in IDX and their listings do not appear on this website. Some properties listed with participating firms do not appear on this website at the request of the seller.
Motions, briefs, responses, and replies should be printed single-sided. Appendices should be printed double-sided. The parties must only include the file-marked copies of each PDF document after they have been filed with the Clerk of the Court or the electronic filing system. Each binder should be appropriately tabbed and indexed.
If a party submits any proposed order to the Court, including an agreed protective order, the party shall email the proposed order in Word format to reno_orders@txnd.uscourts.gov with the case number and document number of the accompanying motion in the subject line. The parties are not to use this email address for any other purpose.
Current Memberships: State Bar of Texas; Amarillo Area Bar Association; Amarillo Area Women's Bar Association; Federal Magistrate Judges Association; Texas Bar Foundation, Sustaining Life Fellow
Dr. Campbell is the Director of the Interdiciplinary Pathobiology Program. Her overall research emphasis is the elucidation of molecular mechanisms of chlamydial pathogenesis. Chlamydia pneumoniae, a human respiratory pathogen, has been associated with cardiovascular disease and found in atherosclerotic lesions. A major current focus is on elucidating the role of C. pneumoniae in atherogenesis through the use of animal models of C. pneumoniae infection and atherosclerosis and in vitro models. These models are also being used to investigate therapeutic interventions and develop preventive strategies. Efforts are also focused on host/pathogen interactions to elucidate the mechanisms by which Chlamydia enters the host and the host receptors involved.
In her construction and government contracts practice, Lee-Ann represents clients in both the prosecution and defense of claims on public and private projects. She regularly counsels clients in cases involving federal and state Miller Act and Prompt Payment Act claims, claims for delay and extended general conditions, and other complex contractual disputes. She has significant experience litigating claims surrounding the construction and improvement of highways/infrastructure and large-scale federal buildings, including new embassy compounds and other secured federal buildings.
In her insurance practice, Lee-Ann represents corporate policyholders in disputed claims and coverage litigation matters. Her practice includes claims for business interruption, contingent business interruption, first-party catastrophe, property damage, and bad faith/extra-contractual insurance disputes with insurance carriers.
Lee-Ann grew up working in the field and shop with her father, who owned a metal fabrication and construction firm. This experience has given her a unique perspective and understanding of project management. It has facilitated her ability to find creative, practical solutions to resolve claims and disputes in all areas of her practice.
Lee Ann has experience with every phase of the litigation process, including pre-trial case investigation and evaluation, taking and defending critical fact and expert witness depositions, developing expert witnesses, arguing dispositive motions, and trial work.
Clients rely on Lee Ann to manage, structure, document, negotiate and close complicated financing transactions considering their legal protections. She is immersed and invested in client needs and business objectives. She is a pragmatic strategist and partner, solution-oriented as well as cost and efficiency focused.
I practice adolescent medicine and provide care for transgender and gender-nonconforming children, adolescents and young adults. I founded and direct our Transgender Health Program, where we offer medical care for transgender and gender-nonconforming youth from age 4 to their 25th birthday.
At the Transgender Health Program, we meet patients and their families where they are in their journey and use evidence-based treatment guidelines to deliver care. As a resource for the community, we provide support for our patients and their families and caregivers. We are training students, residents and fellows to provide culturally competent care for this population.
I want all children and adolescents to grow up happy, and both mentally and physically healthy. I want them to succeed and live to their full potential, especially my transgender and gender- nonconforming patients. I advocate for them and their needs unceasingly.
I have received awards for my care of transgender and gender-nonconforming youth, including the Dennis and Judy Shepard Family Values Award from the Matthew Shepard Foundation, which advocates for LGBT rights and the Cincinnati Human Rights Campaign Award for my care of LGBT patients and families. This recognition would not have been possible without the awesome transgender team that works with me.
In my research, my colleagues and I are trying to standardize care for transgender and gender-nonconforming youth. We gather data to figure out the most effective treatment regimens and best ways to help this patient population get the quality health services they need.
As a faculty member at the University of Buffalo, I have studied the signaling pathways and transcriptional networks that regulate the differentiation of immune cells such as B and T lymphocytes and how they are impaired in autoimmune diseases. These studies have been funded both by the NIH and by private foundations including the Lupus Research Institute, the Alliance for Lupus Research, the International Myeloma Foundation and the American Cancer Society. I have been particularly interested in identifying the roles of the transcription factor Ets1 in B cell differentiation and B cell tolerance to self-antigens. Mice lacking Ets1 develop an autoimmune disease with similarities to human lupus and the human Ets1 gene has been identified as a susceptibility locus for a number of different human autoimmune diseases. To mechanistically understand how Ets1 regulates immune cell function and prevents development of autoimmune disease, my lab has extensively investigated the phenotypes of mice lacking Ets1 either globally or in B cells to identify pathways and target genes that are important in the autoimmune phenotype. My lab has also been interested in signaling pathways that regulate the expression and activity of immune cells, including the BCR signaling pathway, Toll-like receptor pathways, the CD22/SHP1 inhibitory pathway and the Notch pathway. Recently, we've developed an interest in the B cell co-receptor signaling pathway involving CD19/CD21 binding to C3d deposited on the surface of pathogens. We also have an interest in understanding how Ets1 cooperates with IL17RA signaling to regulate skin immune responses to bacterial infection.
Pharmaceutical, device, and biotechnology companies frequently collaborate with basic scientists and physicians within an academic medical center to help advance science and improve patient care. These relationships are important in achieving scientific breakthroughs and in establishing the effectiveness and safety of promising new therapies. In order to assure objectivity in clinical research and patient care, the Northwestern University Feinberg School of Medicine (Feinberg), Northwestern Memorial HealthCare, Children's Hospital of Chicago Medical Center, and the Shirley Ryan AbilityLab have adopted integrity policies that require research and clinical faculty (in full-time, part-time, and unpaid/voluntary categories) to report compensated and uncompensated external industry relationships. Patients are encouraged to discuss these disclosures with their physician as well as to inquire as to how these relationships are overseen by Feinberg. To learn more about our Disclosure and Professional Integrity Policy, and the conflict of interest policies of our joint affiliate survey partners, please go to our Office for Regulatory Affairs Policies page.
Being diagnosed with a serious illness is often one of the most difficult things a person and their family can endure. My training and experience help to ensure that my patients benefit from the multi-disciplinary, goal-directed approach that is at the core of palliative medicine. Anticipating the physical, emotional, social, and spiritual burdens that come with serious illness allows me to help diminish their impact. Focusing on each person's specific needs helps smooth out the journey, both during treatment and at end-of-life. 041b061a72